At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
In Brief
A Phase 3 clinical trial evaluating Testosterone Transdermal System (Androderm 5 mg patch) for Spinal Cord Injury and Hypogonadism. Completed, enrolled 31 participants across 2 sites.
Detailed Summary
It has long been recognized that co-morbidity associated with multiple metabolic syndrome, such as adverse body composition, insulin resistance and autonomic nervous system impairment, may lead to significant increase in cardiovascular morbidity and mortality. It is unclear whether the co-morbidity evident in this population are due directly to their immobility or are the result of unfavorable changes in their underlying hormonal milieu. The purpose of this study is to determine the effect of testosterone replacement therapy in hypogonadal males on: body composition, i.e. lean tissue and fat mass, glucose tolerance, resting energy expenditure, autonomic-cardiovascular integrity, muscular strength, psychological assessment
Study Details
Timeline
Interventions
Testosterone Transdermal System (Androderm 5 mg patch)